Organogenesis: Jumps on Q4 revenue beat, 2021 forecast

Organogenesis Holdings

17/03/2021 19:26

** Regenerative medicine company Organogenesis Holdings
Inc's shares  ORGO.O  rise 5.5% to $18
    ** ORGO on Tuesday after market reported Q4 rev of $106.8
mln, topping Refinitiv IBES estimates of $93.1 mln, driven by
growth in its advanced wound care products business  urn:newsml:reuters.com:*:nGNXST7Mc
    ** Co forecast 2021 rev between $390 mln and $405 mln, the
midpoint of which is above expectations of $395.6 mln
    ** At least 2 brokerages raise PTs on stock after results 
    ** Brokerage BTIG believes ORGO can outperform through 2021;
hikes PT to $20 from $17, implying an upside of 17.2% to ORGO's
last close
    ** ORGO shares have more than doubled in value this year, as
of last close

 (Reporting by Amruta Khandekar)
 ((Amruta.Khandekar@thomsonreuters.com;))